Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Growth Hormone Treatment”

477 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 477 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04305496
What this trial is testing

Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast Cancer

Who this might be right for
Locally Advanced (Inoperable) or Metastatic Breast Cancer
AstraZeneca 818
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07658183
What this trial is testing

A Clinical Trial Comparing the Efficacy and Safety of Different Doses of BL0175 Injection in Treating Postmenopausal Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer (Locally Advanced or Metastatic)
Shanghai Best-Link Bioscience, LLC 120
Post-approval studies (Phase 4)UnknownNCT00145353
What this trial is testing

Insulin NovoRapid Versus Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose

Who this might be right for
Type 1 Diabetes Mellitus
Odense University Hospital 16
Very early researchUnknownNCT05660356
What this trial is testing

Growth Hormone Deficiency in Mild Traumatic Brain Injury

Who this might be right for
Growth Hormone TreatmentGrowth Hormone DeficiencyConcussion, Mild+1 more
University of Calgary 20
Not applicableUnknownNCT06455956
What this trial is testing

Use of miRNAs in Growth Hormone Deficiency (GHD)

Who this might be right for
Growth Hormone Deficiency
University of Parma 400
Not applicableLooking for participantsNCT06106477
What this trial is testing

Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer

Who this might be right for
Breast Cancer
Medical College of Wisconsin 20
Not applicableStudy completedNCT06307457
What this trial is testing

HR+/HER2- Metastatic Breast Cancer Patients Treated With Palbociclib Together With an Aromatase Inhibitor From 2017 to 2023 in Denmark.

Who this might be right for
Breast Cancer
Pfizer 604
Large-scale testing (Phase 3)Study completedNCT00294164
What this trial is testing

Safety and Efficacy Trial of Serostim® in the Treatment of Subjects With Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)

Who this might be right for
Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)Human Immunodeficiency Virus Infections
EMD Serono 245
Large-scale testing (Phase 3)Study completedNCT00557336
What this trial is testing

Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational Age

Who this might be right for
Foetal Growth ProblemSmall for Gestational Age
Novo Nordisk A/S 160
Testing effectiveness (Phase 2)Study completedNCT01576861
What this trial is testing

Long-Term Efficacy and Safety of Growth Hormone Replacement Therapy in Chronic Heart Failure

Who this might be right for
Growth Hormone DeficiencyChronic Heart Failure
Federico II University 28
Large-scale testing (Phase 3)Study completedNCT00082628
What this trial is testing

Treatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) Patients

Who this might be right for
HIV InfectionsLipodystrophy
EMD Serono 326
Large-scale testing (Phase 3)Study completedNCT00943995
What this trial is testing

Three Times Weekly (TIW) Growth Hormone Therapy in Children on Hemodialysis

Who this might be right for
Kidney Failure, ChronicRenal Dialysis
Nationwide Children's Hospital 3
Large-scale testing (Phase 3)Study completedNCT02382939
What this trial is testing

A Trial to Compare the Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® FlexPro® for 26 Weeks in Previously Human Growth Hormone Treated Adults With Growth Hormone Deficiency

Who this might be right for
Adult Growth Hormone DeficiencyGrowth Hormone Disorder
Novo Nordisk A/S 92
Large-scale testing (Phase 3)Study completedNCT00489528
What this trial is testing

Growth Hormone in the Treatment of HIV-Associated Wasting

Who this might be right for
HIV InfectionsHIV Wasting Syndrome
EMD Serono
Post-approval studies (Phase 4)Study completedNCT00521300
What this trial is testing

Preoperative Octreotide Treatment of Acromegaly

Who this might be right for
Acromegaly
St. Olavs Hospital 62
Not applicableStudy completedNCT00334945
What this trial is testing

Evaluate the Effect of Growth Hormone (GH) Treatment on Fibroblast Growth Factor 23, a Known Phosphaturic Agent

Who this might be right for
Growth Disorders
University of Alabama at Birmingham 35
Early research (Phase 1)Study completedNCT01359488
What this trial is testing

VRS-317 in Adult Subjects With Growth Hormone Deficiency

Who this might be right for
Growth Hormone Deficiency
Versartis Inc. 50
Early research (Phase 1)Active Not RecruitingNCT05870579
What this trial is testing

[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 28
Large-scale testing (Phase 3)Looking for participantsNCT07062965
What this trial is testing

Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Who this might be right for
Breast Cancer
Pfizer 400
Post-approval studies (Phase 4)Study completedNCT01877512
What this trial is testing

GH and Cardiovascular Risk Factors

Who this might be right for
Growth Hormone DeficiencyCardiovascular DiseasesMetabolic Syndrome+2 more
Amsterdam UMC, location VUmc 32
Next Page